Firering Strategic Minerals: From explorer to producer. Watch the video here.
I will also add that by purchasing a huge amount of shares in total, but spreading that amount over many days, Michael Tobin is trying NOT to move the share price with his purchases.
He wants as many shares as he can get for as low a price as he can get. He is not buying as a director, he is buying as an investor.
The signal to other investors cannot be clearer.
Gum T. It seems obvious to say it, but you may have missed the point so it's worth saying again, but director purchases don't move the share price because they purchase significant amounts. Director purchases move the share price because it's a clear signal to other investors that those on the inside of the business see the company's shares as a worthwhile investment.
Some director purchases seem made to bolster a flagging share price, or a token effort from board members. A recent NFX round of fund-raising saw a director make a sole pruchase of £5k. This to me seemed more of an insult than a genuine expression of faith in the company's prospects.
In contrast, Michael Tobin's purchases have been both large and frequent. Go to the LSE page for any other company and click on the Director Deals icon near the top of the page. Now do the same for BOOM, and compare them.
Add up the amount of times Tobin has purchased within the past 12 months, for example, and add up the amount of shares he has bought, and add up the total amount he has paid for those shares. He has bought a significant number of them on the open market, paying full market price. Make a note of the share price he has paid for those shares.
It is a good sign for private investors when board members of a company have skin in the game, because they are investing in the company and not just drawing a salary. Many investors, myself included, look for director purchases as a key indicator of whether to invest in a company.
What Michael Tobin is doing at BOOM isn't purchasing a token amount in a fundraising, he isn't bolstering a flagging share price. He is buying more shares more often than I have ever seen before, at near all-time highs. He has such a significant stake in the company already that he doesn't need to buy more to reassure investors.
Tobin knows the company's prospects better than us PIs. He is privy to real-time data and doesn't have to rely on backward-looking RNS'd financial reports.
The only reason he is buying these amounts of shares is because he sees this as a money-making opportunity of a lifetime. He sees significant upside to the share price, in the near to medium term. There is no other reason for him to tie-up so much of his personal wealth in the company unless he expects to get back a lot more.
My average here is £7. I topsliced some at £21-£22, but I have bought the shares all back in the past week. I am stunned that more people can't see it.
My agenda is to hold long-term and make a big profit based on correct predictions. None of your predictions will come true while you are a shareholder.
But GLALTH ;)
I'll still be here long after you've sold out in frustration for a quick 10%.
I'd be careful of celebrating just yet. There's no reason to think that Nemean's 3+% won't be next on the selling block.
And 4D aren't "holding back news to wait until the seller is cleared". That's illegal.
Just bought in this morning, SP28? Looking for a quick pump n dump? The more exclamation marks in someone's posts the less likely I am to believe what they say.
I'd be careful about ramping this up to £3+ by the end of the day, £4+ tomorrow, £5+ the day after that. Yu Group's results have been great for a while. The last set of numbers was superb and look where the share price was last week.
This is still a relatively unknown company, operating in a sector where investors are very wary.
If the share price stays above £2.80 by the end of tomorrow, I'll call that a win.
Tobin has bought 3 separate amount of at least £10k in the past 7 days.
On top of the enormous holding he already has.
This isn't merely a gesture of support for the company, it's because he sees it still represents a fantastic money-making opportunity at these prices.
AIM pharma investments are designed to disappoint.
No 35p close today, no RNS today, no RNS Monday. It'll be a long time before this is at 70p.
Expect delays, slippages, extensions, and you won't be disappointed.
I hold.
If that were true, and that much revenue is coming down the pipeline, DVRG wouldn't have signed the deal with Riverfort.
I'd take your predictions with a grain of salt. Allow for slippages, delayed orders, increasing production costs.
I like the buyout of the production company, and the amount of money in the loan facility, but it is coming at a huge cost to the company, and will punish shareholders.
Riverfort will be a constant seller over the life of the loan, dragging the share price down and selling into any strength.
To see what this kind of funding arrangement does to a company's shareprice in the long-term, look at Versarien (VRS) who signed 2 deals with Lanstead, starting 2 years ago, and Nuformix (NFX) who also signed a deal with Lanstead several months ago. Like the look of those charts? That's what we'll be seeing with DVRG.
This is now a strictly LONG term prospect, so I have sold down half of my holding.
In the UK, share warrants are classed as Capital Gains/Losses, not income tax. Unless your profession is officially "trader". Which I am pretty sure Tobin ain't...
Other countries, such as the US (or Denmark according to the previous link), treat it differently, so be careful which jurisdiction you are looking at.
A very clear statement of intent from the board.
Since Jan 1st 2022, there have been 6 separate purchases by 6 separate board members, with prices paid ranging from 699p down to 550p.
Amount of shares purchased: 185,000
Amount paid for these shares: over £1.16m
UK Stock market is not great for capital increases based on share price.
However, you have received over 10 years of dividends. If you had reinvested these dividends into AV, your capital stake would have increased.